Optimi Health gets closer to completion of its 20,000 sq. ft. production and research facility in British Columbia.
Optimi Health gets closer to completion of its 20,000 sq. ft. production and research facility in British Columbia.
Psyched Wellness continues pre-clinical work on its AME-1 extract.
MindMed Inc commences trading on the NASDAQ exchange under the symbol "MNMD".
Red Light Holland seeks to enter the (legal) medicinal psilocybin market in Oregon.
In 2020, investors were able to reap spectacular returns from psychedelic stock warrants. With a new rally starting in the sector, a there is a NEW opportunity in these warrants.
Numinus' Phase I clinical trial will evaluate safety/tolerance properties of its Psilocybe mushroom product.
U.S. support for legalizing cannabis for medicinal use has hit a new record-high: 91%. Strong bipartisan support. Next: psychedelic drugs.
Champignon Brands has had its Cease Trade Order lifted and can resume trading on the CSE effective April 23, 2021 (symbol: SHRM).
MindMed Inc (CAN:MMED / US:MMEDF) has received approval to commence trading on the NASDAQ starting April 27th. Symbol: MNMD.
With atai Life Sciences filing for a $100 million IPO financing, the countdown to IPO day has begun.
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now